BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25795196)

  • 21. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
    Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
    AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidental findings at initial imaging workup of patients with prostate cancer: clinical significance and outcomes.
    Elmi A; Tabatabaei S; Talab SS; Hedgire SS; Cao K; Harisinghani M
    AJR Am J Roentgenol; 2012 Dec; 199(6):1305-11. PubMed ID: 23169722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
    Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
    Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
    Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
    Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
    Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
    Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum prostate-specific antigen and the biologic progression of prostate cancer.
    Kabalin JN; McNeal JE; Johnstone IM; Stamey TA
    Urology; 1995 Jul; 46(1):65-70. PubMed ID: 7541589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.
    Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J
    Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
    Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
    BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.
    Panje C; Panje T; Putora PM; Kim SK; Haile S; Aebersold DM; Plasswilm L
    Radiat Oncol; 2015 Feb; 10():47. PubMed ID: 25880635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MRI staging of prostate cancer with the combined endorectal body phased-array coil and histologic correlation].
    Pegios W; Bentas W; Wittmann L; Mack MG; Zangos S; Söllner O; Binder J; Fellbaum C; Jonas D; Vogl TJ
    Rofo; 2003 Dec; 175(12):1660-6. PubMed ID: 14661137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate-specific antigen for prostate cancer staging in a population-based register.
    Sandblom G; Holmberg L; Damber JE; Hugosson J; Johansson JE; Lundgren R; Mattsson E; Nilsson J; Varenhorst E
    Scand J Urol Nephrol; 2002; 36(2):99-105. PubMed ID: 12028682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
    MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
    Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation for clinical staging parameters of prostate neoplasm].
    Zhong CY; Liu M; Zhang LQ; Wan B
    Zhonghua Nan Ke Xue; 2003 Apr; 9(2):100-2. PubMed ID: 12749126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].
    Baccos A; Schiavina R; Zukerman Z; Busato F; Gaudiano C; Salizzoni E; Fiorentino M; Golfieri R; Martorana G
    Urologia; 2012; 79(2):116-22. PubMed ID: 22522463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does body-coil magnetic-resonance imaging have a role in the preoperative staging of patients with clinically localized prostate cancer?
    Allen DJ; Hindley R; Clovis S; O'Donnell P; Cahill D; Rottenberg G; Popert R
    BJU Int; 2004 Sep; 94(4):534-8. PubMed ID: 15329107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.